Research Use OnlyRecovery
KPV
KPV, an alpha-MSH-derived tripeptide studied for anti-inflammatory and gut-barrier research.
€49.95per vial
1
Eligibility screening required before purchase.
Estimating delivery to your location…
Alpha-MSH-derived tripeptide
Studied for anti-inflammatory signaling
Gut-barrier research
What The Research Shows
Inflammation
NF-kB and cytokine endpoints are the primary research focus.
Gut barrier
Intestinal-barrier and mucosal models are widely documented.
Recovery
Tissue-recovery endpoints are studied across protocols.
How It Works
KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone. Research studies its anti-inflammatory signaling, NF-kB pathway modulation, and gut-barrier and tissue-recovery endpoints.
- Alpha-MSH-derived tripeptide
- Studied for anti-inflammatory signaling
- Gut-barrier research
- Third-party CoA available
About KPV
KPV is a tripeptide fragment of alpha-MSH studied for its anti-inflammatory signaling and gut-barrier research applications.
“KPV is our reference anti-inflammatory tripeptide for gut-barrier models. Consistency between vials has been excellent.”
Sarah K.
Immunology research, 35
Questions
It is the C-terminal Lys-Pro-Val fragment of alpha-MSH, studied for the anti-inflammatory activity attributed to that region.
Third-party testedCertificate of analysisPublished referencesResearch use only
For Research Use Only. Not intended for human or animal use. These products are not drugs, foods, or cosmetics and are not intended to diagnose, treat, cure, or prevent any disease.